All articles tagged with #earnings report
Constellation Brands exceeded fiscal second-quarter expectations with adjusted earnings of $3.74 per share and revenue of $2.63 billion, yet underlying consumer demand remains soft. While beer shipments rose 5.5%, depletions declined slightly, signaling cautious spending. The company is pivoting to special occasions and acquiring ready-to-drink brand SpikedAde for up to $353 million to diversify beyond core beer sales.
Constellation Brands exceeded fiscal second-quarter expectations with adjusted earnings of $3.74 per share and revenue of $2.63 billion, yet underlying consumer demand remains soft. While beer shipments rose 5.5%, depletions declined slightly, signaling cautious spending. The company is pivoting to special occasions and acquiring ready-to-drink brand SpikedAde for up to $353 million to diversify beyond core beer sales.
Constellation Brands reported fiscal second-quarter adjusted earnings of $3.74 per share, exceeding Wall Street estimates of $3.56, on revenue of $2.63 billion. While beer revenue rose 5% to $2.47 billion, underlying consumer demand metrics, known as depletions, declined slightly, indicating cautious spending. The company is pivoting toward special occasions and acquiring the ready-to-drink brand SpikedAde for up to $353 million to diversify beyond core beer sales.
Micron Technology is set to report its fourth-quarter results on September 30, a date that has drawn investor attention due to the ongoing tightness in the memory-chip market. While demand from AI hyperscalers continues to support higher pricing, the company has warned that supply shortages will not ease until after 2027. New capacity expansions are not expected to come online until 2027–2028, suggesting potential upside if demand remains strong. However, the stock’s valuation and cyclical risks have led some analysts to recommend holding rather than buying at current levels.
Ondas, a Palantir-backed drone company, reported a 1,236% jump in quarterly revenue driven by demand for its autonomous aircraft systems, but posted a wider-than-expected loss, sending its stock lower despite the revenue surge.
Remedy Entertainment touts CONTROL Resonant as a must-own title on day one across major platforms, with the studio aiming to turn it into a lasting franchise; early hands-on praise and strong pre-orders buoy expectations in a crowded autumn release window, while Max Payne 1 & 2 remakes remain in development.
Speculation is mounting that GTA 6 could be revealed soon, with Take-Two's August 7 earnings report (released early on a Friday) and a rumored August 6 trailer lining up with a summer marketing push; GTA 6 is set for November 19 on PS5 and Xbox Series X|S, with analysts predicting strong early demand, though some voices in the industry remain cautious.
Novo Nordisk raised its full-year outlook after Q2 results that beat on adjusted sales (up 7% to 78.49 billion DKK) and adjusted operating profit (up 11%). The company now expects sales and operating profit to fall up to 6% at constant exchange rates this year, a milder decline than previously anticipated, thanks to stronger U.S. demand for GLP-1 drugs (including Wegovy and Ozempic) and new international launches. Despite the upbeat guidance, the stock slid about 6% as investors weigh Novo’s reliance on GLP-1 therapies and its duopoly with Eli Lilly in that space.
Fans are buzzing that Take-Two's August 7 quarterly earnings release—moving to a pre-market schedule with an 8 AM conference call—could reveal GTA 6 updates, a pattern fans have leveraged before as Rockstar information often surfaces around earnings; Take-Two is kicking off GTA 6 marketing this summer ahead of its November 19 digital-only launch on PS5 and Xbox Series X|S.
German police searched Deutsche Bank offices in Frankfurt and Berlin as part of a money-laundering probe; the bank said it is cooperating, and shares fell about 2.7% ahead of its Q4/year-end earnings release.
Netflix's stock declined despite the success of 'Stranger Things' as the company faces challenges in completing its $72 billion acquisition of Warner Bros. assets, with delays due to antitrust issues and rival bids, while upcoming earnings may influence its stock performance.
Micron Technology hit an all-time high of $294.37 amid investor buying ahead of its dividend payout, following strong quarterly earnings that doubled net income to $5.24 billion and revenue of $13.6 billion, with future revenue guidance set higher at $18.7 billion.
Nvidia's stock has surged due to AI-driven GPU demand, with a strong earnings outlook expected after its February 25, 2026, earnings report, and a $500 billion order backlog through 2026. Despite high valuation, its consistent revenue growth and strategic expansions make it a compelling buy before the report, though it wasn't listed among the top 10 stocks recommended by The Motley Fool.
Nike's stock fell over 9% after the company beat second-quarter estimates but issued disappointing guidance, expecting revenue to decline in the third quarter, indicating that its turnaround may take longer than anticipated.
Micron's stock has surged 176% in 2025 amid AI-driven demand, but recent declines and cautious investor sentiment raise questions about whether the hype justifies its valuation, which remains low compared to peers. The upcoming earnings report could clarify if the optimism is justified or if the stock's rally is overextended.